Barclays analyst Andrew Mok lowered the firm’s price target on UnitedHealth (UNH) to $327 from $391 and keeps an Overweight rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Here’s Why TD Cowen Lowered its UnitedHealth Stock (UNH) Price Target
- UnitedHealth Stock Forecast: Analysts Split As Turnaround Unfolds
- Mixed options sentiment in UnitedHealth with shares up 3.66%
- UnitedHealth price target lowered to $361 from $408 at RBC Capital
- UnitedHealth Stock Forecast: Analysts See Turnaround Upside